Here are three things to know:
1. Ms. Vogt previously served as CEO and director of Aushon Biosystems, a venture-backed company with an immunoassay platform. She has more than 35 years of experience in the global life science research, pharmaceutical, biotech and clinical diagnostics industries.
2. Anika Therapeutics is an orthopedic and regenerative medicine company that develops and manufactures more than 20 products based on its proprietary hyaluronic acid technology.
3. Steven Wheeler, who has served as a director of Anika Therapeutics since 1993 and currently chairs the board’s governance and nominating committee, will retire Feb. 8, 2019.
More articles on biologics:
SpinalCyte’s CybroCell shows positive results for degenerative disc disease pain relief: 5 insights
Regentis Biomaterials to test knee cartilage repair treatment at 11 U.S. sites: 3 notes
Orthobiologics company launches U.S. distributor network: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
